HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 269 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $311,869 | -71.3% | 5,481 | -80.0% | 0.08% | -62.7% |
| Q3 2022 | $1,086,000 | +90.9% | 27,459 | +112.3% | 0.22% | -5.2% |
| Q2 2022 | $569,000 | -10.1% | 12,937 | -16.9% | 0.23% | +275.4% |
| Q3 2021 | $633,000 | +213.4% | 15,566 | +228.5% | 0.06% | +32.6% |
| Q1 2021 | $202,000 | 0.0% | 4,739 | 0.0% | 0.05% | 0.0% |
| Q4 2020 | $202,000 | -36.7% | 4,739 | -61.0% | 0.05% | -33.3% |
| Q3 2020 | $319,000 | +45.0% | 12,139 | +48.1% | 0.07% | -57.1% |
| Q2 2020 | $220,000 | +3042.9% | 8,196 | +1539.2% | 0.16% | +2583.3% |
| Q3 2015 | $7,000 | +250.0% | 500 | +400.0% | 0.01% | +200.0% |
| Q2 2015 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |